By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Newbury Pharmaceuticals AB (publ) (NEWBRY.ST)

STO Currency in SEK
kr 2.84
-kr 0.06
-2.07%
Last Update: 17 Jul 2025, 08:48
kr 68.89M
Market Cap
-4.86
P/E Ratio (TTM)
Forward Dividend Yield
kr 2.35 - kr 4.76
52 Week Range

NEWBRY.ST Stock Price Chart

Explore Newbury Pharmaceuticals AB (publ) interactive price chart. Choose custom timeframes to analyze NEWBRY.ST price movements and trends.

There is nothing to show.

NEWBRY.ST Company Profile

Discover essential business fundamentals and corporate details for Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

4 Feb 2022

Employees

6.00

CEO

Lars Minor

Description

Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden, and Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. The company was incorporated in 2020 and is based in Lund, Sweden.

NEWBRY.ST Financial Timeline

Browse a chronological timeline of Newbury Pharmaceuticals AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 9 Apr 2025

EPS came in at -kr 0.08, while revenue for the quarter reached kr 12.43M.

Earnings released on 24 Jan 2025

EPS came in at -kr 0.19, while revenue for the quarter reached kr 6.54M.

Earnings released on 23 Oct 2024

EPS came in at kr 0.07, while revenue for the quarter reached kr 21.12M.

Earnings released on 10 Jul 2024

EPS came in at -kr 0.39, while revenue for the quarter reached kr 1.39M.

Earnings released on 10 Apr 2024

EPS came in at -kr 0.25, while revenue for the quarter reached kr 3.14M.

Earnings released on 10 Jan 2024

EPS came in at -kr 0.18, while revenue for the quarter reached kr 11.19M.

Earnings released on 11 Oct 2023

EPS came in at -kr 0.24, while revenue for the quarter reached kr 2.83M.

Earnings released on 14 Jun 2023

EPS came in at -kr 0.21, while revenue for the quarter reached kr 5.68M.

Earnings released on 12 Apr 2023

EPS came in at -kr 0.25, while revenue for the quarter reached kr 1.50M.

Earnings released on 11 Jan 2023

EPS came in at -kr 0.29, while revenue for the quarter reached kr 258.00K.

Earnings released on 13 Oct 2022

EPS came in at -kr 0.17, while revenue for the quarter reached kr 644.00K.

Earnings released on 31 Aug 2022

EPS came in at -kr 0.19, while revenue for the quarter reached kr 5.52M.

Earnings released on 28 Feb 2022

EPS came in at -kr 0.19, while revenue for the quarter reached kr 302.00K.

Earnings released on 30 Nov 2021

EPS came in at -kr 0.24.

Earnings released on 31 Aug 2021

EPS came in at -kr 0.09, while revenue for the quarter reached kr 2.83M.

Earnings released on 31 May 2021

EPS came in at -kr 0.15, while revenue for the quarter reached kr 732.00K.

Earnings released on 28 Feb 2021

EPS came in at -kr 0.07.

Earnings released on 30 Nov 2020

EPS came in at -kr 0.01.

NEWBRY.ST Stock Performance

Access detailed NEWBRY.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
NEWBRY.ST
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
NEWBRY.ST
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More